Champions Oncology (CSBR) Operating Leases (2019 - 2026)

Champions Oncology's Operating Leases history runs 8 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• In Q1 2026, Operating Leases fell 47.72% year-over-year to $3.4 million; the TTM figure through Jan 2026 stood at $3.4 million (down 47.72% YoY), while the FY2025 annual figure was $4.6 million, down 23.95% from the prior year.
• Operating Leases was $3.4 million for Q1 2026 at Champions Oncology, down from $5.3 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $9.2 million in Q3 2022 to a low of $3.4 million in Q1 2026.
• Historically, Operating Leases has averaged $6.8 million across 5 years, with a median of $6.8 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Operating Leases surged 48.64% in 2022, then plunged 47.72% in 2026.
• A 5-year view of Operating Leases shows it stood at $9.0 million in 2022, then fell by 24.43% to $6.8 million in 2023, then changed by 0.0% to $6.8 million in 2024, then decreased by 22.23% to $5.3 million in 2025, then slumped by 36.14% to $3.4 million in 2026.
• The last three Operating Leases figures came in at $3.4 million (Q1 2026), $5.3 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.